Compare FSTR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSTR | OSUR |
|---|---|---|
| Founded | 1902 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.8M | 214.1M |
| IPO Year | 1995 | 2000 |
| Metric | FSTR | OSUR |
|---|---|---|
| Price | $28.10 | $3.08 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $32.00 | $3.00 |
| AVG Volume (30 Days) | 19.3K | ★ 518.1K |
| Earning Date | 03-03-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $540,009,000.00 | $167,064,000.00 |
| Revenue This Year | $5.44 | $4.48 |
| Revenue Next Year | $3.05 | $7.76 |
| P/E Ratio | $40.75 | ★ N/A |
| Revenue Growth | ★ 1.74 | N/A |
| 52 Week Low | $17.16 | $2.08 |
| 52 Week High | $32.63 | $3.76 |
| Indicator | FSTR | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 40.22 | 55.57 |
| Support Level | $27.26 | $3.05 |
| Resistance Level | $29.72 | $3.29 |
| Average True Range (ATR) | 1.14 | 0.18 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 24.66 | 44.78 |
L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.